Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$683,883,867
-$211,932,111 QoQ
Shares Held
2,271,813
+0.8% QoQ
Ownership
1.70%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#13
of 764 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. ALNY ranks #3 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in ALNY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $683,883,867 | 2,271,813 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $895,815,978 | 2,252,775 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $662,836,621 | 2,032,680 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $576,769,200 | 2,136,024 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $577,940,655 | 2,456,082 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $653,343,391 | 2,375,535 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $558,117,783 | 2,296,781 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $342,637,140 | 2,292,654 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $390,437,735 | 2,039,798 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $211,380,538 | 1,193,566 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $133,595,058 | 703,354 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $304,769,251 | 1,521,412 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $240,702,851 | 1,012,846 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $243,831,709 | 1,218,184 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $187,384,725 | 1,284,777 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $211,474,756 | 1,295,087 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $215,229,409 | 1,269,191 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $187,844,803 | 994,888 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $151,678,359 | 894,752 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $135,867,701 | 962,304 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $135,037,270 | 1,038,988 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $151,474,814 | 1,040,349 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $133,642,467 | 902,319 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $107,518,220 | 987,765 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||